1. Home
  2. LMAT vs RCKT Comparison

LMAT vs RCKT Comparison

Compare LMAT & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LMAT
  • RCKT
  • Stock Information
  • Founded
  • LMAT 1983
  • RCKT 1999
  • Country
  • LMAT United States
  • RCKT United States
  • Employees
  • LMAT N/A
  • RCKT N/A
  • Industry
  • LMAT Medical/Dental Instruments
  • RCKT Biotechnology: Pharmaceutical Preparations
  • Sector
  • LMAT Health Care
  • RCKT Health Care
  • Exchange
  • LMAT Nasdaq
  • RCKT Nasdaq
  • Market Cap
  • LMAT 2.0B
  • RCKT 1.9B
  • IPO Year
  • LMAT 2006
  • RCKT N/A
  • Fundamental
  • Price
  • LMAT $96.35
  • RCKT $16.82
  • Analyst Decision
  • LMAT Buy
  • RCKT Strong Buy
  • Analyst Count
  • LMAT 7
  • RCKT 9
  • Target Price
  • LMAT $92.83
  • RCKT $53.22
  • AVG Volume (30 Days)
  • LMAT 113.8K
  • RCKT 617.5K
  • Earning Date
  • LMAT 10-31-2024
  • RCKT 11-12-2024
  • Dividend Yield
  • LMAT 0.66%
  • RCKT N/A
  • EPS Growth
  • LMAT 49.21
  • RCKT N/A
  • EPS
  • LMAT 1.82
  • RCKT N/A
  • Revenue
  • LMAT $213,029,000.00
  • RCKT N/A
  • Revenue This Year
  • LMAT $15.09
  • RCKT N/A
  • Revenue Next Year
  • LMAT $9.19
  • RCKT $382.35
  • P/E Ratio
  • LMAT $53.05
  • RCKT N/A
  • Revenue Growth
  • LMAT 14.81
  • RCKT N/A
  • 52 Week Low
  • LMAT $47.72
  • RCKT $15.98
  • 52 Week High
  • LMAT $101.67
  • RCKT $32.53
  • Technical
  • Relative Strength Index (RSI)
  • LMAT 65.31
  • RCKT 43.54
  • Support Level
  • LMAT $86.62
  • RCKT $16.48
  • Resistance Level
  • LMAT $101.67
  • RCKT $17.75
  • Average True Range (ATR)
  • LMAT 2.93
  • RCKT 0.72
  • MACD
  • LMAT 0.67
  • RCKT -0.01
  • Stochastic Oscillator
  • LMAT 68.67
  • RCKT 15.93

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

Share on Social Networks: